Amy Parison's most recent trade in Editas Medicine Inc was a trade of 458 Common Stock done at an average price of $2.6 . Disclosure was reported to the exchange on Sept. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Editas Medicine Inc | Amy Parison | SVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 03 Sep 2025 | 458 | 16,369 (0%) | 0% | 2.6 | 1,189 | Common Stock |
| Editas Medicine Inc | Amy Parison | SVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 07 Aug 2025 | 679 | 16,827 (0%) | 0% | 2.6 | 1,752 | Common Stock |
| Editas Medicine Inc | Amy Parison | SVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 03 Jun 2025 | 446 | 17,506 (0%) | 0% | 1.7 | 769 | Common Stock |
| Editas Medicine Inc | Amy Parison | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2025 | 34,672 | 34,672 | - | - | Stock Option (right to buy) |